“…k* is unaffected by changes in cerebral blood flow that might be affected by drugs or stress, thus reflects only changes in brain AA metabolism. The method is presented in detail elsewhere (Bhattacharjee et al, 2005;Chang et al, 1997;DeGeorge et al, 1991;Hayakawa et al, 2001;Ohata et al, 1982;Rapoport, 2003;Robinson et al, 1992;Soncrant et al, 1988). With it, we showed in unlesioned unanesthetized rats that acute administration of quinpirole, a D 2 -receptor agonist, increased k* for AA in brain regions with high densities of D 2 -receptors, and that the increases could be blocked by the preferential D 2 -receptor antagonist, butaclamol (Bhattacharjee et al, 2005;Bristow et al, 1998;Hayakawa et al, 2001).…”